Back | Next |
home / stock / xoma / xoma message board
Subject | By | Source | When |
---|---|---|---|
daily looks nice but we should know by | my name is | investorshub | 04/19/2018 12:25:14 AM |
News ? Xoma | highstakes | investorshub | 04/18/2018 3:14:21 PM |
what a pumper | my name is | investorshub | 04/07/2018 2:05:01 AM |
What is this news ? | highstakes | investorshub | 04/06/2018 1:35:21 PM |
Volume shows a steady rise up Xoma | highstakes | investorshub | 04/05/2018 2:01:57 PM |
geeze now I really want to buy this stock | my name is | investorshub | 03/28/2018 1:59:35 AM |
looks like a lot of dilution coming | jdlamont | investorshub | 03/28/2018 1:37:22 AM |
Its at the red line Xoma | highstakes | investorshub | 03/17/2018 10:23:22 AM |
there could still be money to be made | my name is | investorshub | 03/09/2018 2:44:34 AM |
Market is correcting. Will be a rockey year. | highstakes | investorshub | 03/09/2018 1:50:14 AM |
bought at 22.78. this was uncalled for drop. | jdlamont | investorshub | 03/08/2018 9:18:19 PM |
Up 7.8%. That was the highest gain on | WovenO2 | investorshub | 03/08/2018 4:03:13 AM |
Needs to stay above 200 day. As | WovenO2 | investorshub | 03/07/2018 1:47:08 PM |
chart is starting look interesting again but I | my name is | investorshub | 03/07/2018 1:55:00 AM |
IF any of xoma's clients come up with | jdlamont | investorshub | 03/03/2018 2:22:57 AM |
I tend to agree. The big $$$$$ | WovenO2 | investorshub | 02/13/2018 9:10:04 PM |
being as i ended up so much ive | my name is | investorshub | 02/13/2018 6:03:03 PM |
What reentry would you consider? | WovenO2 | investorshub | 02/13/2018 5:29:12 PM |
biowatcher: This would be a good time to consider a position. ER on the 9th | biowatcher | investorshangout | 03/05/2016 5:00:55 PM |
Hattlem: Dumped it all @ 1.91, and will buy it again on the dip, and sell again on the rip. | Hattlem | investorshangout | 11/03/2015 3:56:17 PM |
News, Short Squeeze, Breakout and More Instantly...
EMERYVILLE, Calif., May 14, 2024 (GLOBE NEWSWIRE) -- XOMA Corporation (NASDAQ:XOMA), the biotech royalty aggregator, announced today that member...
EMERYVILLE, Calif., May 14, 2024 (GLOBE NEWSWIRE) -- XOMA Corporation (NASDAQ: XOMA), the biotech royalty aggregator, announced today that members of its Executive Team will participate in the H.C. Wainwright 2 nd Annual Bioconnect Investor Conference at NASDAQ being held on May 20, 2024, in ...
Earned $9 million milestone upon U.S. Food and Drug Administration’s approval of Day One’s OJEMDA™ (tovorafenib); XOMA is entitled to receive a mid-single digit royalty on OJEMDA™ sales Acquired Kinnate Pharmaceuticals, adding at least $9.5 million in...